RxSight, Inc. (RXST)

RxSight Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	142.09	139.93	89.08	49.01	22.59	14.68
Revenue Growth (YoY)	10.75%	57.08%	81.77%	116.90%	53.92%	554.98%
Cost of Revenue	35.55	40.98	35.31	27.68	18.08	12.97
Gross Profit	106.53	98.94	53.77	21.33	4.52	1.71
Selling, General & Admin	113.25	101.52	74.9	58.99	33.1	15.36
Research & Development	38.77	34.28	28.95	25.66	24.2	21.75
Operating Expenses	152.02	135.8	103.85	84.65	57.3	37.11
Operating Income	-45.48	-36.86	-50.09	-63.32	-52.79	-35.41
Interest Expense	-0.02	-0.02	-3.31	-4.95	-3.68	-0.51
Interest & Investment Income	9.84	9.47	6.57	1.52	0.05	0.54
Other Non Operating Income (Expenses)	-	-	-	-	7.74	63.01
EBT Excluding Unusual Items	-35.66	-27.41	-46.82	-66.75	-48.68	27.64
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.01
Other Unusual Items	-	-	-1.77	-	-	-
Pretax Income	-35.66	-27.41	-48.59	-66.75	-48.68	27.63
Income Tax Expense	0.07	0.05	0.02	0.01	0.01	0.06
Earnings From Continuing Operations	-	-27.46	-48.61	-66.76	-48.69	27.58
Net Income	-35.73	-27.46	-48.61	-66.76	-48.69	27.58
Preferred Dividends & Other Adjustments	-	-	-	-	-	24.21
Net Income to Common	-35.73	-27.46	-48.61	-66.76	-48.69	3.37
Net Income Growth	-	-	-	-	-	-78.15%
Shares Outstanding (Basic)	41	39	34	28	14	4
Shares Outstanding (Diluted)	41	39	34	28	14	6
Shares Change (YoY)	7.62%	12.81%	24.56%	103.02%	146.28%	-73.12%
EPS (Basic)	-0.88	-0.71	-1.41	-2.41	-3.57	0.91
EPS (Diluted)	-0.88	-0.71	-1.41	-2.41	-3.57	0.15
EPS Growth	-	-	-	-	-	-97.42%
Free Cash Flow	-22.2	-22.39	-46.41	-61.24	-46.65	-37.74
Free Cash Flow Per Share	-0.55	-0.58	-1.35	-2.21	-3.42	-6.82
Gross Margin	74.98%	70.71%	60.36%	43.52%	19.99%	11.62%
Operating Margin	-32.01%	-26.34%	-56.23%	-129.21%	-233.64%	-241.21%
Profit Margin	-25.15%	-19.62%	-54.57%	-136.22%	-215.50%	22.93%
Free Cash Flow Margin	-15.62%	-16.00%	-52.10%	-124.97%	-206.47%	-257.13%
EBITDA	-42.55	-33.28	-46.01	-59.43	-48.81	-31.55
EBITDA Margin	-29.95%	-23.79%	-51.65%	-121.28%	-216.05%	-214.96%
D&A For EBITDA	2.93	3.58	4.08	3.88	3.98	3.85
EBIT	-45.48	-36.86	-50.09	-63.32	-52.79	-35.41
EBIT Margin	-32.01%	-26.34%	-56.23%	-129.21%	-233.64%	-241.21%
Effective Tax Rate	-	-	-	-	-	0.21%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q